Becton Dickinson‘s (NYSE: BDX) life sciences division issued a recall last month for some of its blood collection tubes, citing a manufacturing flaw that resulted in devices without sufficient additive.
The company explained that an internal investigation found that Vacutainer Citrate Plus tubes with too little additive led to falsely-shortened clotting time and could impact patient therapy.
Get the full story at our sister site, Drug Delivery Business News.
The post Manufacturing fault prompts BD to recall blood collection tubes appeared first on MassDevice.
from MassDevice https://ift.tt/2EuZthS
Cap comentari:
Publica un comentari a l'entrada